ACTELION PHARMACEUTICALS Canada Inc.

Actelion is a new biopharmaceutical company focusing on the discovery, development and marketing of innovative drugs for significant unmet medical needs.

Tracleer^TM (Bosentan) is a new oral medication for the treatment of pulmonary arterial hypertension.  Tracleer^TM belongs to a new class of medication called “endothelin receptor antagonist” (ERA).

Click here to close this window
and return to the Dermatology Update Sponsors Page.